In this interview, Joyce explains the impact her work could have on society, tells us about the benefits that open-source technology has had on her research and highlights the importance of researcher support programs.

Brain-computer interface (BCI) developer Blackrock Neurotech has announced that its MoveAgain BCI has received Breakthrough Device designation from the US Food and Drug Administration (FDA). To find out more, we spoke with Blackrock’s chairman and president, Florian Solzbacher.

In this instalment of Science Futures, we hear from Tijmen Bos, a PhD candidate at the Vrije Universiteit Amsterdam and the University of Amsterdam. Tijmen discusses the impact his research could have on society and how interactions with industry have helped progress his research and prepare him for the end of his PhD.

Thermo Scientific Proteome Discoverer 3.0 software offers a wide range of comprehensive tools for proteomics studies. In this interview, we learn more about the latest version, how it leverages artificial intelligence and what this means for proteomics researchers.

With the advent of electronic health records, it is now possible to access larger, more comprehensive volumes of medical statistics than ever before. In this Insight, Chris Patrick, CEO of cloud provider Nuvodia, explores how this could lead to a medical data revolution.

The University of Aberdeen’s HPC usage rocketed by 50% during the height of the pandemic. In this insight, Dean Phillips, assistant director, digital and information services at the University explains how pioneering research was able to continue remotely when moved off campus.

In this instalment of Science Futures, we hear from Max Lennart Feuerstein. Max tells us more about his research and how it could drive technical enhancements of data acquisition workflows

Here we highlight some of the innovations featured at the 69^th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics.

In this interview, Alexandra Richardson tells us more about her research, the role that technology is playing in it and how important industry partnerships have been.

To find out more about how AI can improve melanoma diagnosis, Technology Networks spoke to Dr. Kiran Motaparthi, director of dermatopathology and clinical associate professor of dermatology at the University of Florida and Julianna Ianni, PhD, vice president of AI R&D, Proscia.